RedHill Biopharma Ltd.

RDHLNASDAQHealthcare● Active

$0.88

$-0.15(-14.22%)

Market Cap$2750000

P/E Ratio—

52W High$3.31

52W Low$0.71

Avg Volume61K

Open$0.90

Beta4.97

Overview

RedHill Biopharma Ltd. (RDHL) Revenue

Annual & quarterly revenue history · segment & region breakdown

RDHL · revenue · updated Jun 9, 2026

Core revenue metrics

Trailing 12 months

RedHill Biopharma Ltd. trailing twelve-month (TTM) revenue is $0.01B, an increase of 0.00% year-over-year from — in FY.

TTM revenue

$0.01B

4-quarter sum · USD

YoY growth

+0.00%

vs FY —

Price / sales

0.34×

mktCap ÷ TTM rev

Revenue per day

$0M

Est. TTM ÷ 365

Revenue / employee

$273K

35 employees

—

5Y CAGR

—

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · RedHill Biopharma Ltd. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

– · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth

RDHL revenue by year · RDHL revenue history · RDHL annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income RedHill Biopharma Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

RedHill Biopharma Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from RedHill Biopharma Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

RDHL revenue · 4 questions

RDHL's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 0.00% year-over-year from — in FY.

RDHL revenueRDHL annual revenuewhat is RDHL revenueRDHL TTM revenue

▸ Source: FMP · RedHill Biopharma Ltd. SEC filings · GAAP · RedHill Biopharma Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026